These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6585179)

  • 1. Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.
    Gnarpe H; Belsheim J; Blomqvist C; Lundbäck A
    Antimicrob Agents Chemother; 1984 Feb; 25(2):179-81. PubMed ID: 6585179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
    Birnbaum J; Kahan FM; Kropp H; MacDonald JS
    Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilastatin does not alter superoxide dismutase activity.
    Proctor RA; Textor JA
    Antimicrob Agents Chemother; 1985 Nov; 28(5):691-2. PubMed ID: 3867330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do imipenem and cilastatin interfere with the determination of serum creatinine?].
    Dauchy F
    Pathol Biol (Paris); 1988 May; 36(5):511-2. PubMed ID: 3043349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroprotective effect of imipenem/cilastatin in reducing cyclosporine toxicity.
    Sido B; Hammer C; Mraz W; Krombach F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1755-8. PubMed ID: 3469804
    [No Abstract]   [Full Text] [Related]  

  • 8. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D4-dipeptidase.
    Köller M; Brom J; Raulf M; König W
    Biochem Biophys Res Commun; 1985 Sep; 131(2):974-9. PubMed ID: 3863619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the mammalian beta-lactamase renal dipeptidase (dehydropeptidase-I) by (Z)-2-(acylamino)-3-substituted-propenoic acids.
    Graham DW; Ashton WT; Barash L; Brown JE; Brown RD; Canning LF; Chen A; Springer JP; Rogers EF
    J Med Chem; 1987 Jun; 30(6):1074-90. PubMed ID: 3495664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilastatin-sensitive dehydropeptidase I enzymes from three sources all catalyze carbapenem hydrolysis and conversion of leukotriene D4 to leukotriene E4.
    Farrell CA; Allegretto NJ; Hitchcock MJ
    Arch Biochem Biophys; 1987 Jul; 256(1):253-9. PubMed ID: 3038022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.
    Norrby SR; Alestig K; Björnegård B; Burman LA; Ferber F; Huber JL; Jones KH; Kahan FM; Kahan JS; Kropp H; Meisinger MA; Sundelof JG
    Antimicrob Agents Chemother; 1983 Feb; 23(2):300-7. PubMed ID: 6573157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
    Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of imipenem-cilastatin in neonates.
    Freij BJ; McCracken GH; Olsen KD; Threlkeld N
    Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Takamura S; Hata T; Kumagaya J; Yamabe T
    Jpn J Antibiot; 1986 Jun; 39(6):1620-5. PubMed ID: 3463803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance and imipenem.
    Calandra G; Ricci F; Wang C; Brown K
    Lancet; 1986 Aug; 2(8502):340-1. PubMed ID: 2874348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Fujimoto H; Ikeda K; Yamamoto K; Taguchi S; Shirakawa K
    Jpn J Antibiot; 1986 Jun; 39(6):1607-11. PubMed ID: 3463801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
    Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
    Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.